drugs psp patients clinical trial practicalities intervention effective participants taking study drug deteriorate slowly placebo group diseases alzheimer decline slow inconsistent begin psp comparison runs course rapidly predictably require 18 month trial 1,000 2,000 patients determine drug effective alzheimer probably need 12 months 200 300 patients sort power detect drug disease modifying effect psp says u.c. san francisco boxer line conducting clinical trials psp faster expensive psp rare disease clinical trials condition eligible incentives enable faster drug approval u.s. food drug administration european medicines agency psp uncommon researchers anticipated having hard time recruiting trial participants enrollment gone better expected says